- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
Dishman Carbogen Amcis Limited's Q1 FY27 earnings call highlighted a soft quarter with revenue de-growth of 4% to INR 677.6 Cr (from INR 708 Cr) and EBITDA falling to INR 60 Cr (from INR 140.6 Cr), primarily due to a postponed INR 1 Cr order and forex impact. **Key Takeaways:**...